Global Parkinson's Disease (PD) Drugs Market Professional Survey Report 2019

Publisher Name :
Date: 06-Sep-2019
No. of pages: 117
Inquire Before Buying

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.

The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain traction in the market for parkinsons drugs throughout the estimated period.

The global Parkinson's Disease (PD) Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Parkinson's Disease (PD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease (PD) Drugs market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson's Disease (PD) Drugs in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Parkinson's Disease (PD) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- Boehringer Ingelheim

- GlaxoSmithKline

- Novartis

- Teva Pharmaceutical Industries

- AbbVie

- Abital Pharma

- Addex Therapeutics

- Biogen

- Eisai

- Eli Lilly

- F. Hoffmann-La Roche

- H. Lundbeck

- Impax Laboratories

- Kyowa Hakko Kirin

- Otsuka Pharmaceutical

- Pfizer

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- Dopamine Agonist

- Monoamine Oxidase Inhibitors

- Acetylcholinesterase Inhibitors

- Glutamate Inhibitors

Segment by Application

- Hospital

- Family

Global Parkinson's Disease (PD) Drugs Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Parkinson's Disease (PD) Drugs
1.1 Definition of Parkinson's Disease (PD) Drugs
1.2 Parkinson's Disease (PD) Drugs Segment by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Parkinson's Disease (PD) Drugs Segment by Applications
1.3.1 Global Parkinson's Disease (PD) Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Family
1.4 Global Parkinson's Disease (PD) Drugs Overall Market
1.4.1 Global Parkinson's Disease (PD) Drugs Revenue (2014-2025)
1.4.2 Global Parkinson's Disease (PD) Drugs Production (2014-2025)
1.4.3 North America Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
1.4.4 Europe Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
1.4.5 China Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
1.4.6 Japan Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
1.4.8 India Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs
2.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
2.4 Industry Chain Structure of Parkinson's Disease (PD) Drugs
3 Development and Manufacturing Plants Analysis of Parkinson's Disease (PD) Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Parkinson's Disease (PD) Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Parkinson's Disease (PD) Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Parkinson's Disease (PD) Drugs Production and Capacity Analysis
4.2 Parkinson's Disease (PD) Drugs Revenue Analysis
4.3 Parkinson's Disease (PD) Drugs Price Analysis
4.4 Market Concentration Degree
5 Parkinson's Disease (PD) Drugs Regional Market Analysis
5.1 Parkinson's Disease (PD) Drugs Production by Regions
5.1.1 Global Parkinson's Disease (PD) Drugs Production by Regions
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Regions
5.2 Parkinson's Disease (PD) Drugs Consumption by Regions
5.3 North America Parkinson's Disease (PD) Drugs Market Analysis
5.3.1 North America Parkinson's Disease (PD) Drugs Production
5.3.2 North America Parkinson's Disease (PD) Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Parkinson's Disease (PD) Drugs Import and Export
5.4 Europe Parkinson's Disease (PD) Drugs Market Analysis
5.4.1 Europe Parkinson's Disease (PD) Drugs Production
5.4.2 Europe Parkinson's Disease (PD) Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Parkinson's Disease (PD) Drugs Import and Export
5.5 China Parkinson's Disease (PD) Drugs Market Analysis
5.5.1 China Parkinson's Disease (PD) Drugs Production
5.5.2 China Parkinson's Disease (PD) Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Parkinson's Disease (PD) Drugs Import and Export
5.6 Japan Parkinson's Disease (PD) Drugs Market Analysis
5.6.1 Japan Parkinson's Disease (PD) Drugs Production
5.6.2 Japan Parkinson's Disease (PD) Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Parkinson's Disease (PD) Drugs Import and Export
5.7 Southeast Asia Parkinson's Disease (PD) Drugs Market Analysis
5.7.1 Southeast Asia Parkinson's Disease (PD) Drugs Production
5.7.2 Southeast Asia Parkinson's Disease (PD) Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Parkinson's Disease (PD) Drugs Import and Export
5.8 India Parkinson's Disease (PD) Drugs Market Analysis
5.8.1 India Parkinson's Disease (PD) Drugs Production
5.8.2 India Parkinson's Disease (PD) Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Parkinson's Disease (PD) Drugs Import and Export
6 Parkinson's Disease (PD) Drugs Segment Market Analysis (by Type)
6.1 Global Parkinson's Disease (PD) Drugs Production by Type
6.2 Global Parkinson's Disease (PD) Drugs Revenue by Type
6.3 Parkinson's Disease (PD) Drugs Price by Type
7 Parkinson's Disease (PD) Drugs Segment Market Analysis (by Application)
7.1 Global Parkinson's Disease (PD) Drugs Consumption by Application
7.2 Global Parkinson's Disease (PD) Drugs Consumption Market Share by Application (2014-2019)
8 Parkinson's Disease (PD) Drugs Major Manufacturers Analysis
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.1.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Teva Pharmaceutical Industries
8.4.1 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.4.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 AbbVie
8.5.1 AbbVie Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.5.2 AbbVie Product Introduction, Application and Specification
8.5.3 AbbVie Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Abital Pharma
8.6.1 Abital Pharma Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.6.2 Abital Pharma Product Introduction, Application and Specification
8.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Addex Therapeutics
8.7.1 Addex Therapeutics Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.7.2 Addex Therapeutics Product Introduction, Application and Specification
8.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biogen
8.8.1 Biogen Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.8.2 Biogen Product Introduction, Application and Specification
8.8.3 Biogen Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Eisai
8.9.1 Eisai Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.9.2 Eisai Product Introduction, Application and Specification
8.9.3 Eisai Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Eli Lilly
8.10.1 Eli Lilly Parkinson's Disease (PD) Drugs Production Sites and Area Served
8.10.2 Eli Lilly Product Introduction, Application and Specification
8.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 F. Hoffmann-La Roche
8.12 H. Lundbeck
8.13 Impax Laboratories
8.14 Kyowa Hakko Kirin
8.15 Otsuka Pharmaceutical
8.16 Pfizer
9 Development Trend of Analysis of Parkinson's Disease (PD) Drugs Market
9.1 Global Parkinson's Disease (PD) Drugs Market Trend Analysis
9.1.1 Global Parkinson's Disease (PD) Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Parkinson's Disease (PD) Drugs Regional Market Trend
9.2.1 North America Parkinson's Disease (PD) Drugs Forecast 2019-2025
9.2.2 Europe Parkinson's Disease (PD) Drugs Forecast 2019-2025
9.2.3 China Parkinson's Disease (PD) Drugs Forecast 2019-2025
9.2.4 Japan Parkinson's Disease (PD) Drugs Forecast 2019-2025
9.2.5 Southeast Asia Parkinson's Disease (PD) Drugs Forecast 2019-2025
9.2.6 India Parkinson's Disease (PD) Drugs Forecast 2019-2025
9.3 Parkinson's Disease (PD) Drugs Market Trend (Product Type)
9.4 Parkinson's Disease (PD) Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Parkinson's Disease (PD) Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Parkinson's Disease (PD) Drugs
Table Global Parkinson's Disease (PD) Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Parkinson's Disease (PD) Drugs Production Market Share by Types in 2018
Figure Dopamine Agonist Product Picture
Figure Monoamine Oxidase Inhibitors Product Picture
Figure Acetylcholinesterase Inhibitors Product Picture
Figure Glutamate Inhibitors Product Picture
Table Global Parkinson's Disease (PD) Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Parkinson's Disease (PD) Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Family
Figure Global Parkinson's Disease (PD) Drugs Revenue (Million USD) (2014-2025)
Figure Global Parkinson's Disease (PD) Drugs Production (K Pcs) (2014-2025)
Figure North America Parkinson's Disease (PD) Drugs Market Size (Million USD) (2014-2025)
Figure Europe Parkinson's Disease (PD) Drugs Market Size (Million USD) (2014-2025)
Figure China Parkinson's Disease (PD) Drugs Market Size (Million USD) (2014-2025)
Figure Japan Parkinson's Disease (PD) Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Market Size (Million USD) (2014-2025)
Figure India Parkinson's Disease (PD) Drugs Market Size (Million USD) (2014-2025)
Table Parkinson's Disease (PD) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs in 2018
Figure Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
Figure Industry Chain Structure of Parkinson's Disease (PD) Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Parkinson's Disease (PD) Drugs Manufacturing Plants Distribution
Table Parkinson's Disease (PD) Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Parkinson's Disease (PD) Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Parkinson's Disease (PD) Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Parkinson's Disease (PD) Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Parkinson's Disease (PD) Drugs Production Share by Manufacturers in 2018
Table Parkinson's Disease (PD) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Parkinson's Disease (PD) Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2018
Table Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Parkinson's Disease (PD) Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Production Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Production Market Share by Regions in 2018
Table Global Parkinson's Disease (PD) Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2018
Table Global Parkinson's Disease (PD) Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Consumption Market Share by Regions 2014-2019
Figure North America Parkinson's Disease (PD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Parkinson's Disease (PD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Parkinson's Disease (PD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Parkinson's Disease (PD) Drugs Production, Consumption Import and Export (K Pcs)
Figure China Parkinson's Disease (PD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Parkinson's Disease (PD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Parkinson's Disease (PD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Parkinson's Disease (PD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Parkinson's Disease (PD) Drugs Production, Consumption Import and Export (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Parkinson's Disease (PD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Parkinson's Disease (PD) Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Parkinson's Disease (PD) Drugs Market Share by Application (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Boehringer Ingelheim Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Novartis Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Novartis Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Novartis Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Novartis Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Novartis Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Novartis Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table AbbVie Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table AbbVie Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table AbbVie Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table AbbVie Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure AbbVie Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table AbbVie Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Abital Pharma Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Abital Pharma Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Abital Pharma Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abital Pharma Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Abital Pharma Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Abital Pharma Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Abital Pharma Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Addex Therapeutics Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Biogen Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Biogen Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Biogen Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Biogen Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Biogen Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Biogen Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Eisai Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Eisai Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Eisai Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Eisai Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Eisai Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Eisai Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table Eli Lilly Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Eli Lilly Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
Table Eli Lilly Parkinson's Disease (PD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
Table Eli Lilly Parkinson's Disease (PD) Drugs Production Market Share (2014-2019)
Figure Eli Lilly Parkinson's Disease (PD) Drugs Revenue Market Share (2014-2019)
Table Eli Lilly Parkinson's Disease (PD) Drugs Main Business and Markets Served
Table F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table H. Lundbeck Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Impax Laboratories Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Production Sites and Area Served
Table Pfizer Parkinson's Disease (PD) Drugs Production Sites and Area Served
Figure Global Parkinson's Disease (PD) Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Parkinson's Disease (PD) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Parkinson's Disease (PD) Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Parkinson's Disease (PD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Parkinson's Disease (PD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Parkinson's Disease (PD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Parkinson's Disease (PD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Parkinson's Disease (PD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Parkinson's Disease (PD) Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Parkinson's Disease (PD) Drugs by Application (2019-2025)
Table Parkinson's Disease (PD) Drugs Distributors List
Table Parkinson's Disease (PD) Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • 2017-2025 World Rasagiline Tablet Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 02-Dec-2019        Price: US 2800 Onwards        Pages: 108
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Rasagiline Tablet , covering Global tota......
  • 2017-2025 World Parkinson's Disease Drug Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 27-Nov-2019        Price: US 2800 Onwards        Pages: 143
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Parkinson's Disease Drug , covering Global total......
  • Global Parkinsons disease Drug Market Report and 2020 Outlook
    Published: 27-Nov-2019        Price: US 2900 Onwards        Pages: 122
    Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease. The global Parkinsons disease Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Parkinsons disease Drug volume and value at global level, regional level and company level. Fro......
  • Global Parkinson's Disease Drug Market Professional Survey Report 2019
    Published: 21-Nov-2019        Price: US 3500 Onwards        Pages: 115
    The global Parkinson's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Parkinson's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, ap......
  • Global Rasagiline Tablet Market Study 2016-2026, by Segment (0.5 mg, 1 mg,) , by Market (Clinics and Hospital, Households,) , by Company (Orchid Healthcare, Teva,)
    Published: 29-Oct-2019        Price: US 1800 Onwards        Pages: 55
    Summary The global Rasagiline Tablet market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - 0.5 mg - 1 mg - Others Demand Coverage (Market Size & Forecast, Consumer Distribution): - Clinics and Hospital - Households - Caring Center - Others Company Coverage (Sales data, Main ......
  • Global Parkinson's Disease Drug Market Study 2016-2026, by Segment (Sinemet-CR, Trastal,) , by Market (Under 40 Years Old, 40-65 Years Old,) , by Company (Merck, Akorn,)
    Published: 24-Oct-2019        Price: US 1800 Onwards        Pages: 65
    Summary The global Parkinson's Disease Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Sinemet-CR - Trastal - Madopar - COMT Inhibitor - Others Demand Coverage (Market Size & Forecast, Consumer Distribution): - Under 40 Years Old - 40-65 Years Old - Above 65 Years Old......
  • Global and China Rasagiline Tablet Market Research by Company, Type & Application 2013-2025
    Published: 19-Oct-2019        Price: US 2000 Onwards        Pages: 64
    Summary Market Segment as follows: By Type - 0.5 mg - 1 mg - Others By Application - Clinics and Hospital - Households - Caring Center - Others By Company - Orchid Healthcare - Teva - Apotex - Taj Pharmaceuticals The main contents of the report including: Section 1: Product definition, type and application, global and China market overview; ......
  • Global Rasagiline Tablet Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Rasagiline Tablet market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rasagiline Tablet volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rasagiline Tablet market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, e......
  • Global Parkinson's Disease Drug Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 09-Sep-2019        Price: US 2900 Onwards        Pages: 187
    The Parkinson's Disease Drug market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Parkinson's Disease Drug. Global Parkinson's Disease Drug industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, m......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs